Global Metronidazole API Market Research Report 2024

Publication ID:

PB503244917

Publication Date:

March 29, 2024

Pages:

102

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global Metronidazole API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Metronidazole API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metronidazole API.
Report Scope
The Metronidazole API market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metronidazole API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metronidazole API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hongyuan Pharmaceutical
Shijiazhuang No.4 Pharmaceutical
Huanggang Yinhe Aarti Pharmaceutical
Saikang Pharmaceutical
Wuyao Pharmaceutical
Tongji Pharmaceutical
Dandong Qianjin Pharmaceutical
Unichem Laboratories
CordenPharma
Polpharma
Aarti Drugs Ltd
Hebei Guangxiang
Segment by Type
Glyoxal Process
Ethylenediamine Process
Others
Segment by Application
Metronidazole Tablets
Metronidazole Capsules
Metronidazole Injection
Others
Production by Region
China
India
Europe
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Metronidazole API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Metronidazole API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Metronidazole API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Metronidazole API Market Overview
1.1 Product Definition
1.2 Metronidazole API Segment by Type
1.2.1 Global Metronidazole API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Glyoxal Process
1.2.3 Ethylenediamine Process
1.2.4 Others
1.3 Metronidazole API Segment by Application
1.3.1 Global Metronidazole API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Metronidazole Tablets
1.3.3 Metronidazole Capsules
1.3.4 Metronidazole Injection
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Metronidazole API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Metronidazole API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Metronidazole API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Metronidazole API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Metronidazole API Production Market Share by Manufacturers (2019-2024)
2.2 Global Metronidazole API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Metronidazole API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Metronidazole API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Metronidazole API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Metronidazole API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Metronidazole API, Product Offered and Application
2.8 Global Key Manufacturers of Metronidazole API, Date of Enter into This Industry
2.9 Metronidazole API Market Competitive Situation and Trends
2.9.1 Metronidazole API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Metronidazole API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Metronidazole API Production by Region
3.1 Global Metronidazole API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Metronidazole API Production Value by Region (2019-2030)
3.2.1 Global Metronidazole API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Metronidazole API by Region (2025-2030)
3.3 Global Metronidazole API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Metronidazole API Production by Region (2019-2030)
3.4.1 Global Metronidazole API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Metronidazole API by Region (2025-2030)
3.5 Global Metronidazole API Market Price Analysis by Region (2019-2024)
3.6 Global Metronidazole API Production and Value, Year-over-Year Growth
3.6.1 China Metronidazole API Production Value Estimates and Forecasts (2019-2030)
3.6.2 India Metronidazole API Production Value Estimates and Forecasts (2019-2030)
3.6.3 Europe Metronidazole API Production Value Estimates and Forecasts (2019-2030)
4 Metronidazole API Consumption by Region
4.1 Global Metronidazole API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Metronidazole API Consumption by Region (2019-2030)
4.2.1 Global Metronidazole API Consumption by Region (2019-2024)
4.2.2 Global Metronidazole API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Metronidazole API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Metronidazole API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Metronidazole API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Metronidazole API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Metronidazole API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Metronidazole API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Metronidazole API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Metronidazole API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Metronidazole API Production by Type (2019-2030)
5.1.1 Global Metronidazole API Production by Type (2019-2024)
5.1.2 Global Metronidazole API Production by Type (2025-2030)
5.1.3 Global Metronidazole API Production Market Share by Type (2019-2030)
5.2 Global Metronidazole API Production Value by Type (2019-2030)
5.2.1 Global Metronidazole API Production Value by Type (2019-2024)
5.2.2 Global Metronidazole API Production Value by Type (2025-2030)
5.2.3 Global Metronidazole API Production Value Market Share by Type (2019-2030)
5.3 Global Metronidazole API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Metronidazole API Production by Application (2019-2030)
6.1.1 Global Metronidazole API Production by Application (2019-2024)
6.1.2 Global Metronidazole API Production by Application (2025-2030)
6.1.3 Global Metronidazole API Production Market Share by Application (2019-2030)
6.2 Global Metronidazole API Production Value by Application (2019-2030)
6.2.1 Global Metronidazole API Production Value by Application (2019-2024)
6.2.2 Global Metronidazole API Production Value by Application (2025-2030)
6.2.3 Global Metronidazole API Production Value Market Share by Application (2019-2030)
6.3 Global Metronidazole API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Hongyuan Pharmaceutical
7.1.1 Hongyuan Pharmaceutical Metronidazole API Corporation Information
7.1.2 Hongyuan Pharmaceutical Metronidazole API Product Portfolio
7.1.3 Hongyuan Pharmaceutical Metronidazole API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Hongyuan Pharmaceutical Main Business and Markets Served
7.1.5 Hongyuan Pharmaceutical Recent Developments/Updates
7.2 Shijiazhuang No.4 Pharmaceutical
7.2.1 Shijiazhuang No.4 Pharmaceutical Metronidazole API Corporation Information
7.2.2 Shijiazhuang No.4 Pharmaceutical Metronidazole API Product Portfolio
7.2.3 Shijiazhuang No.4 Pharmaceutical Metronidazole API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Shijiazhuang No.4 Pharmaceutical Main Business and Markets Served
7.2.5 Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
7.3 Huanggang Yinhe Aarti Pharmaceutical
7.3.1 Huanggang Yinhe Aarti Pharmaceutical Metronidazole API Corporation Information
7.3.2 Huanggang Yinhe Aarti Pharmaceutical Metronidazole API Product Portfolio
7.3.3 Huanggang Yinhe Aarti Pharmaceutical Metronidazole API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Huanggang Yinhe Aarti Pharmaceutical Main Business and Markets Served
7.3.5 Huanggang Yinhe Aarti Pharmaceutical Recent Developments/Updates
7.4 Saikang Pharmaceutical
7.4.1 Saikang Pharmaceutical Metronidazole API Corporation Information
7.4.2 Saikang Pharmaceutical Metronidazole API Product Portfolio
7.4.3 Saikang Pharmaceutical Metronidazole API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Saikang Pharmaceutical Main Business and Markets Served
7.4.5 Saikang Pharmaceutical Recent Developments/Updates
7.5 Wuyao Pharmaceutical
7.5.1 Wuyao Pharmaceutical Metronidazole API Corporation Information
7.5.2 Wuyao Pharmaceutical Metronidazole API Product Portfolio
7.5.3 Wuyao Pharmaceutical Metronidazole API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Wuyao Pharmaceutical Main Business and Markets Served
7.5.5 Wuyao Pharmaceutical Recent Developments/Updates
7.6 Tongji Pharmaceutical
7.6.1 Tongji Pharmaceutical Metronidazole API Corporation Information
7.6.2 Tongji Pharmaceutical Metronidazole API Product Portfolio
7.6.3 Tongji Pharmaceutical Metronidazole API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Tongji Pharmaceutical Main Business and Markets Served
7.6.5 Tongji Pharmaceutical Recent Developments/Updates
7.7 Dandong Qianjin Pharmaceutical
7.7.1 Dandong Qianjin Pharmaceutical Metronidazole API Corporation Information
7.7.2 Dandong Qianjin Pharmaceutical Metronidazole API Product Portfolio
7.7.3 Dandong Qianjin Pharmaceutical Metronidazole API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Dandong Qianjin Pharmaceutical Main Business and Markets Served
7.7.5 Dandong Qianjin Pharmaceutical Recent Developments/Updates
7.8 Unichem Laboratories
7.8.1 Unichem Laboratories Metronidazole API Corporation Information
7.8.2 Unichem Laboratories Metronidazole API Product Portfolio
7.8.3 Unichem Laboratories Metronidazole API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Unichem Laboratories Main Business and Markets Served
7.7.5 Unichem Laboratories Recent Developments/Updates
7.9 CordenPharma
7.9.1 CordenPharma Metronidazole API Corporation Information
7.9.2 CordenPharma Metronidazole API Product Portfolio
7.9.3 CordenPharma Metronidazole API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 CordenPharma Main Business and Markets Served
7.9.5 CordenPharma Recent Developments/Updates
7.10 Polpharma
7.10.1 Polpharma Metronidazole API Corporation Information
7.10.2 Polpharma Metronidazole API Product Portfolio
7.10.3 Polpharma Metronidazole API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Polpharma Main Business and Markets Served
7.10.5 Polpharma Recent Developments/Updates
7.11 Aarti Drugs Ltd
7.11.1 Aarti Drugs Ltd Metronidazole API Corporation Information
7.11.2 Aarti Drugs Ltd Metronidazole API Product Portfolio
7.11.3 Aarti Drugs Ltd Metronidazole API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Aarti Drugs Ltd Main Business and Markets Served
7.11.5 Aarti Drugs Ltd Recent Developments/Updates
7.12 Hebei Guangxiang
7.12.1 Hebei Guangxiang Metronidazole API Corporation Information
7.12.2 Hebei Guangxiang Metronidazole API Product Portfolio
7.12.3 Hebei Guangxiang Metronidazole API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Hebei Guangxiang Main Business and Markets Served
7.12.5 Hebei Guangxiang Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Metronidazole API Industry Chain Analysis
8.2 Metronidazole API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Metronidazole API Production Mode & Process
8.4 Metronidazole API Sales and Marketing
8.4.1 Metronidazole API Sales Channels
8.4.2 Metronidazole API Distributors
8.5 Metronidazole API Customers
9 Metronidazole API Market Dynamics
9.1 Metronidazole API Industry Trends
9.2 Metronidazole API Market Drivers
9.3 Metronidazole API Market Challenges
9.4 Metronidazole API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Hongyuan Pharmaceutical
Shijiazhuang No.4 Pharmaceutical
Huanggang Yinhe Aarti Pharmaceutical
Saikang Pharmaceutical
Wuyao Pharmaceutical
Tongji Pharmaceutical
Dandong Qianjin Pharmaceutical
Unichem Laboratories
CordenPharma
Polpharma
Aarti Drugs Ltd
Hebei Guangxiang

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂